Universal Vision Biotechnology Co., Ltd. (TPEX:3218)

Market Cap	17.45B
Revenue (ttm)	4.28B
Net Income (ttm)	1.12B
Shares Out	84.72M
EPS (ttm)	13.22
PE Ratio	15.58
Forward PE	14.21
Dividend	7.50 (3.58%)
Ex-Dividend Date	Mar 26, 2025

Volume	104,312
Average Volume	179,885
Open	208.00
Previous Close	209.50
Day's Range	204.50 - 208.00
52-Week Range	158.50 - 264.00
Beta	0.51
RSI	52.66
Earnings Date	Aug 11, 2025

About ANSYS

Universal Vision Biotechnology Co., Ltd. operates a chain of eye care clinics in Taiwan and China. The company offers optical devices, glasses, lens, and vision aid products. It is also involved in leasing of medical devices. In addition, the company offers hospital management, optometric, and technical consultancy services, as well as provides medical and scientific prescription eyeglasses. Further, it offers sunglasses, fashionable and reading glasses, and progressive lenses for presbyopia. Additionally, the company provides contact lenses fo...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1992
• Employees: 401
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 3218

Financial Performance

In 2024, TPEX:3218's revenue was 4.23 billion, an increase of 3.58% compared to the previous year's 4.08 billion. Earnings were 1.06 billion, an increase of 1.88%.